Skip to content

Statins and HIV: how can the REPRIEVE findings be implemented in the real world?

The REPRIEVE trial symposium panel discussion at IAS 2023. Photo by @iasociety.

Diagnosis and treatment for high blood pressure need to be funded as part of HIV treatment programmes

Professor Francois Venter at IAS 2023. Photo by Roger Pebody.

Bictegravir safe and effective in pregnancy

Rhiannon Neale Photography

COVID-19 vaccine effectiveness lower in people with HIV who inject drugs

Dr Joseph Puyat at IAS 2023.

Very high HIV incidence among people who inject drugs in South Africa

Photo by Marco Verch. Creative Commons licence.

More options for second-line treatment in children shown to be safe and effective

Dr Victor Musiime at IAS 2023.

South Africa: dropping out of HIV care is deadly

Dr Haroon Moolla at IAS 2023.

Doravirine/islatravir just as effective as Biktarvy in previously untreated people

Professor Jürgen Rockstroh at IAS 2023.

The amber light: the World Health Organization’s position when an HIV viral load is “suppressed but not undetectable”

Dr Lara Vojnov at IAS 2023.